<i>TARDBP</i> mutations in motoneuron disease with frontotemporal lobar degeneration
Lina Benajiba(Inserm), Alexis Brice(School of the Art Institute of Chicago), Isabelle Le Ber(Inserm), Eric Guedj(Centre de Résonance Magnétique Biologique et Médicale), Philippe Couratier(Centre Hospitalier Universitaire de Limoges), Vincent Meininger(Générale de Santé), Didier Hannequin(Hôpital Charles-Nicolle), Lucette Lacomblez(Sorbonne Université), François Salachas(Sorbonne Université), Dominique Campion(Hôpital Charles-Nicolle), William Camu(Hôpital Gui de Chauliac), Solenn Legallic, Agnès Camuzat(Inserm), Bruno Dubois(Pitié-Salpêtrière Hospital), Mathieu Lacoste(Centre Hospitalier Universitaire de Limoges), Véronique Golfier(Centre Hospitalier Universitaire de Rennes), Catherine Thomas-Antérion(Bellevue Hospital Center), M. Décousus(Bellevue Hospital Center)
Cited by 302
Related Papers
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
|New England Journal of Medicine|1994|2.2k
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
|Nature Genetics|2008|1.5k
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
|The Lancet|1996|1.3k
Apathy and the Functional Anatomy of the Prefrontal Cortex–Basal Ganglia Circuits
|Cerebral Cortex|2005|1.3k